Current Research Studies

Cancer – ADVL1823: Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Condition or Therapy:

Pediatric Solid Tumors, Relapsed Pediatric Acute Leukemias


Cancer and Blood Disorders
Study Number: ADVL1823

What is the goal of this study?

This study aims to find the effects of a drug or combination of drugs on patients with pediatric solid tumors or relapsed pediatric acute leukemia.

Who can join the study?

This study may be a good fit for children and young adults who: 

  • Are 30 years of age or younger

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106.